Thermo Fisher Scientific Inc. (TMO)

Market Cap	207.28B
Revenue (ttm)	42.37B
Net Income (ttm)	6.14B
Shares Out	382.50M
EPS (ttm)	15.95
PE Ratio	33.97
Forward PE	23.73
Dividend	$1.56 (0.29%)
Ex-Dividend Date	Sep 13, 2024

Volume	863,523
Open	540.00
Previous Close	540.75
Day's Range	538.00 - 544.80
52-Week Range	463.99 - 627.88
Beta	0.79
Analysts	Strong Buy
Price Target	651.56 (+20.24%)
Earnings Date	Oct 23, 2024

About TMO

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechno...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1956
• Employees: 122,000
• Stock Exchange: NYSE
• Ticker Symbol: TMO
• Website: https://www.thermofisher.com

Financial Performance

In 2023, Thermo Fisher's revenue was $42.86 billion, a decrease of -4.58% compared to the previous year's $44.92 billion. Earnings were $6.00 billion, a decrease of -13.74%.

Analyst Forecast

According to 19 analysts, the average rating for TMO stock is "Strong Buy." The 12-month stock price forecast is $651.56, which is an increase of 20.24% from the latest price.

Price Target

$651.56

(20.24% upside)

Analyst Consensus: Strong Buy